Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4330050
Disease: WHO Grade II Glioma
WHO Grade II Glioma
0.030 GeneticVariation disease BEFREE This is the first study, to our knowledge, to validate the prognostic importance of MGMT promoter methylation in patients with grade II glioma treated with combined radiotherapy and temozolomide and highlights its potential prognostic value beyond IDH1/2 mutation status. 29955793 2018
CUI: C4330050
Disease: WHO Grade II Glioma
WHO Grade II Glioma
0.030 GeneticVariation disease BEFREE 207 IDH mutated grade II glioma samples were analyzed with a median follow-up of 6.9 years. 29663171 2018
CUI: C4330050
Disease: WHO Grade II Glioma
WHO Grade II Glioma
0.030 Biomarker disease BEFREE We explored a noninvasive method to reveal IDH1 status by using a quantitative radiomics approach for grade II glioma. 28004160 2017